NasdaqGS:GEHCMedical Equipment
Did GE HealthCare's (GEHC) Cardiac Imaging Deal with CardioNavix Just Shift Its Investment Narrative?
GE HealthCare announced in early September a distribution and services agreement with CardioNavix to expand access to Flyrcado™, its new cardiac PET imaging agent, to hospitals and outpatient practices across the U.S.
This collaboration is positioned to increase adoption of advanced cardiac imaging in office-based care settings, highlighted by Flyrcado's higher diagnostic efficacy over traditional methods.
We'll now examine what this expanded access to Flyrcado in outpatient settings could...